{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:16:40Z","timestamp":1782814600652,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,9,8]],"date-time":"2009-09-08T00:00:00Z","timestamp":1252368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00125-009-1514-5","type":"journal-article","created":{"date-parts":[[2009,9,7]],"date-time":"2009-09-07T18:37:59Z","timestamp":1252348679000},"page":"2374-2384","source":"Crossref","is-referenced-by-count":28,"title":["Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack"],"prefix":"10.1007","volume":"52","author":[{"given":"C.","family":"Gysemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Callewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nelson-Holte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Overbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Eizirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,8]]},"reference":[{"key":"1514_CR1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/jaut.1997.0183","volume":"11","author":"NC Schloot","year":"1998","unstructured":"Schloot NC, Willemen S, Duinkerken G, de Vries RR, Roep BO (1998) Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain. J Autoimmun 11:169\u2013175","journal-title":"J Autoimmun"},{"key":"1514_CR2","doi-asserted-by":"crossref","first-page":"18425","DOI":"10.1073\/pnas.0508621102","volume":"102","author":"GG Pinkse","year":"2005","unstructured":"Pinkse GG, Tysma OH, Bergen CA et al (2005) Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 102:18425\u201318430","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1514_CR3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/intimm\/dxl020","volume":"18","author":"MD McKenzie","year":"2006","unstructured":"McKenzie MD, Dudek NL, Mariana L et al (2006) Perforin and Fas induced by IFN-gamma and TNF-alpha mediate beta cell death by OT-I CTL. Int Immunol 18:837\u2013846","journal-title":"Int Immunol"},{"key":"1514_CR4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.tp.0000191939.68451.d9","volume":"81","author":"VR Sutton","year":"2006","unstructured":"Sutton VR, Estella E, Li C et al (2006) A critical role for granzyme B, in addition to perforin and TNF-alpha, in alloreactive CTL-induced mouse pancreatic beta cell death. Transplantation 81:146\u2013154","journal-title":"Transplantation"},{"key":"1514_CR5","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.2337\/db06-0109","volume":"55","author":"NL Dudek","year":"2006","unstructured":"Dudek NL, Thomas HE, Mariana L et al (2006) Cytotoxic T cells from T cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 55:2412\u20132418","journal-title":"Diabetes"},{"key":"1514_CR6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/BF00400649","volume":"39","author":"T Mandrup-Poulsen","year":"1996","unstructured":"Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005\u20131029","journal-title":"Diabetologia"},{"key":"1514_CR7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s001250100021","volume":"44","author":"DL Eizirik","year":"2001","unstructured":"Eizirik DL, Mandrup-Poulsen T (2001) A choice of death\u2014the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115\u20132133","journal-title":"Diabetologia"},{"key":"1514_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/BST0360321","volume":"36","author":"DL Eizirik","year":"2008","unstructured":"Eizirik DL, Moore F, Flamez D, Ortis F (2008) Use of a systems biology approach to understand pancreatic beta-cell death in type 1 diabetes. Biochem Soc Trans 36:321\u2013327","journal-title":"Biochem Soc Trans"},{"key":"1514_CR9","doi-asserted-by":"crossref","first-page":"48879","DOI":"10.1074\/jbc.M108658200","volume":"276","author":"AK Cardozo","year":"2001","unstructured":"Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276:48879\u201348886","journal-title":"J Biol Chem"},{"key":"1514_CR10","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.2337\/diabetes.54.8.2396","volume":"54","author":"CA Gysemans","year":"2005","unstructured":"Gysemans CA, Ladriere L, Callewaert H et al (2005) Disruption of the gamma-interferon signalling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cells. Diabetes 54:2396\u20132403","journal-title":"Diabetes"},{"key":"1514_CR11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/diabetes.50.5.909","volume":"50","author":"AK Cardozo","year":"2001","unstructured":"Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 50:909\u2013920","journal-title":"Diabetes"},{"key":"1514_CR12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s001250051622","volume":"44","author":"MC Chen","year":"2001","unstructured":"Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 44:325\u2013332","journal-title":"Diabetologia"},{"key":"1514_CR13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00125-002-1017-0","volume":"46","author":"AK Cardozo","year":"2003","unstructured":"Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL (2003) IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255\u2013266","journal-title":"Diabetologia"},{"key":"1514_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diabetes.51.1.55","volume":"51","author":"L Piemonti","year":"2002","unstructured":"Piemonti L, Leone BE, Nano R et al (2002) Human pancreatic islets produce and secrete MCP-1\/CCL2: relevance in human islet transplantation. Diabetes 51:55\u201365","journal-title":"Diabetes"},{"key":"1514_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3727\/000000006783981963","volume":"15","author":"S Merani","year":"2006","unstructured":"Merani S, Truong WW, Hancock W, Anderson CC, Shapiro AM (2006) Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction. Cell Transplant 15:295\u2013309","journal-title":"Cell Transplant"},{"key":"1514_CR16","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2337\/db08-0625","volume":"57","author":"AP Martin","year":"2008","unstructured":"Martin AP, Rankin S, Pitchford S, Charo IF, Furtado GC, Lira SA (2008) Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis and diabetes. Diabetes 57:3025\u20133033","journal-title":"Diabetes"},{"key":"1514_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/107999002753452610","volume":"22","author":"A Kroger","year":"2002","unstructured":"Kroger A, Koster M, Schroeder K, Hauser H, Mueller PP (2002) Activities of IRF-1. J Interferon Cytokine Res 22:5\u201314","journal-title":"J Interferon Cytokine Res"},{"key":"1514_CR18","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1073\/pnas.86.24.9936","volume":"86","author":"T Fujita","year":"1989","unstructured":"Fujita T, Reis LF, Watanabe N, Kimura Y, Taniguchi T, Vilcek J (1989) Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci U S A 86:9936\u20139940","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1514_CR19","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1093\/nar\/25.21.4346","volume":"25","author":"R Pine","year":"1997","unstructured":"Pine R (1997) Convergence of TNF-alpha and IFN-gamma signalling pathways through synergistic induction of IRF-1\/ISGF-2 is mediated by a composite GAS\/kappaB promoter element. Nucleic Acids Res 25:4346\u20134354","journal-title":"Nucleic Acids Res"},{"key":"1514_CR20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1074-7613(00)80444-6","volume":"6","author":"M Lohoff","year":"1997","unstructured":"Lohoff M, Ferrick D, Mittrucker HW et al (1997) Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6:681\u2013689","journal-title":"Immunity"},{"key":"1514_CR21","first-page":"403","volume":"10","author":"D Pavlovic","year":"1999","unstructured":"Pavlovic D, Chen MC, Gysemans CA, Mathieu C, Eizirik DL (1999) The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells. Eur Cytokine Netw 10:403\u2013412","journal-title":"Eur Cytokine Netw"},{"key":"1514_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0092-8674(93)90681-F","volume":"75","author":"T Matsuyama","year":"1993","unstructured":"Matsuyama T, Kimura T, Kitagawa M et al (1993) Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83\u201397","journal-title":"Cell"},{"key":"1514_CR23","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.2337\/diabetes.49.12.1992","volume":"49","author":"CA Gysemans","year":"2000","unstructured":"Gysemans CA, Waer M, Valckx D et al (2000) Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts. Diabetes 49:1992\u20131997","journal-title":"Diabetes"},{"key":"1514_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00403185","volume":"34","author":"DL Eizirik","year":"1991","unstructured":"Eizirik DL, Tracey DE, Bendtzen K, Sandler S (1991) An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta. Diabetologia 34:445\u2013448","journal-title":"Diabetologia"},{"key":"1514_CR25","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI118950","volume":"98","author":"A Hoorens","year":"1996","unstructured":"Hoorens A, Van de Casteele M, Kloppel G, Pipeleers D (1996) Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568\u20131574","journal-title":"J Clin Invest"},{"key":"1514_CR26","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2337\/diabetes.49.7.1116","volume":"49","author":"D Liu","year":"2000","unstructured":"Liu D, Pavlovic D, Chen MC, Flodstrom M, Sandler S, Eizirik DL (2000) Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS\u2212\/\u2212). Diabetes 49:1116\u20131122","journal-title":"Diabetes"},{"key":"1514_CR27","doi-asserted-by":"crossref","first-page":"R1208","DOI":"10.1186\/ar1806","volume":"7","author":"B Klerck De","year":"2005","unstructured":"De Klerck B, Geboes L, Hatse S et al (2005) Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res Ther 7:R1208\u2013R1220","journal-title":"Arthritis Res Ther"},{"key":"1514_CR28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1189\/jlb.0806486","volume":"81","author":"H Kelchtermans","year":"2007","unstructured":"Kelchtermans H, Struyf S, De Klerck B et al (2007) Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production. J Leukoc Biol 81:1044\u20131053","journal-title":"J Leukoc Biol"},{"key":"1514_CR29","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1242\/jcs.026062","volume":"121","author":"DA Cunha","year":"2008","unstructured":"Cunha DA, Hekerman P, Ladriere L et al (2008) Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci 121:2308\u20132318","journal-title":"J Cell Sci"},{"key":"1514_CR30","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1074\/jbc.M607627200","volume":"282","author":"M Cnop","year":"2007","unstructured":"Cnop M, Ladriere L, Hekerman P et al (2007) Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis. J Biol Chem 282:3989\u20133997","journal-title":"J Biol Chem"},{"key":"1514_CR31","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1210\/en.2004-0478","volume":"145","author":"I Kharroubi","year":"2004","unstructured":"Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL (2004) Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145:5087\u20135096","journal-title":"Endocrinology"},{"key":"1514_CR32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/cyto.1998.0426","volume":"11","author":"L Overbergh","year":"1999","unstructured":"Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305\u2013312","journal-title":"Cytokine"},{"key":"1514_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737159.6.1.51","volume":"6","author":"L Overbergh","year":"2006","unstructured":"Overbergh L, Gysemans C, Mathieu C (2006) Quantification of chemokines by real-time reverse transcriptase PCR: applications in type 1 diabetes. Expert Rev Mol Diagn 6:51\u201364","journal-title":"Expert Rev Mol Diagn"},{"key":"1514_CR34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00125-003-1154-0","volume":"46","author":"C Gysemans","year":"2003","unstructured":"Gysemans C, Stoffels K, Giulietti A et al (2003) Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents. Diabetologia 46:1115\u20131123","journal-title":"Diabetologia"},{"key":"1514_CR35","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/db07-0052","volume":"56","author":"HI Callewaert","year":"2007","unstructured":"Callewaert HI, Gysemans CA, Ladriere L et al (2007) Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Diabetes 56:2169\u20132173","journal-title":"Diabetes"},{"key":"1514_CR36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s001250051662","volume":"44","author":"CA Gysemans","year":"2001","unstructured":"Gysemans CA, Pavlovic D, Bouillon R, Eizirik DL, Mathieu C (2001) Dual role of interferon-\u03b3 signalling pathway in sensitivity of pancreatic beta cells to immune destruction. Diabetologia 44:567\u2013574","journal-title":"Diabetologia"},{"key":"1514_CR37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/jaut.2001.0531","volume":"17","author":"T Nakazawa","year":"2001","unstructured":"Nakazawa T, Satoh J, Takahashi K et al (2001) Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1. J Autoimmun 17:119\u2013125","journal-title":"J Autoimmun"},{"key":"1514_CR38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.3086977","volume":"232","author":"K Bendtzen","year":"1986","unstructured":"Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M (1986) Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232:1545\u20131547","journal-title":"Science"},{"key":"1514_CR39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0896-8411(89)90152-2","volume":"2","author":"MD Dayer-Metroz","year":"1989","unstructured":"Dayer-Metroz MD, Wollheim CB, Seckinger P, Dayer JM (1989) A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. J Autoimmun 2:163\u2013171","journal-title":"J Autoimmun"},{"key":"1514_CR40","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/diab.42.12.1845","volume":"42","author":"JO Sandberg","year":"1993","unstructured":"Sandberg JO, Eizirik DL, Sandler S, Tracey DE, Andersson A (1993) Treatment with an interleukin-1 receptor antagonist protein prolongs mouse islet allograft survival. Diabetes 42:1845\u20131851","journal-title":"Diabetes"},{"key":"1514_CR41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2249.1997.3771275.x","volume":"108","author":"JO Sandberg","year":"1997","unstructured":"Sandberg JO, Eizirik DL, Sandler S (1997) IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice. Clin Exp Immunol 108:314\u2013317","journal-title":"Clin Exp Immunol"},{"key":"1514_CR42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncpendmet0783","volume":"4","author":"MY Donath","year":"2008","unstructured":"Donath MY, Mandrup-Poulsen T (2008) The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. Nat Clin Pract Endocrinol Metab 4:240\u2013241","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1514_CR43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.1.06968","volume":"192","author":"M Montolio","year":"2007","unstructured":"Montolio M, Biarnes M, Tellez N, Escoriza J, Soler J, Montanya E (2007) Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation. J Endocrinol 192:169\u2013177","journal-title":"J Endocrinol"},{"key":"1514_CR44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/diabetes.51.2.311","volume":"51","author":"HE Thomas","year":"2002","unstructured":"Thomas HE, Darwiche R, Corbett JA, Kay TW (2002) Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes 51:311\u2013316","journal-title":"Diabetes"},{"key":"1514_CR45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.172.1.291","volume":"172","author":"DB Kaufman","year":"1990","unstructured":"Kaufman DB, Platt JL, Rabe FL, Dunn DL, Bach FH, Sutherland DE (1990) Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary non-function and classic rejection of islet allografts. J Exp Med 172:291\u2013302","journal-title":"J Exp Med"},{"key":"1514_CR46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1067\/msy.2003.236","volume":"134","author":"MS Baker","year":"2003","unstructured":"Baker MS, Chen X, Rotramel AR, Nelson JJ, Kaufman DB (2003) Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets. Surgery 134:134\u2013141","journal-title":"Surgery"},{"key":"1514_CR47","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.7510419","volume":"263","author":"R Kamijo","year":"1994","unstructured":"Kamijo R, Harada H, Matsuyama T et al (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612\u20131615","journal-title":"Science"},{"key":"1514_CR48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-8993(97)00264-3","volume":"759","author":"M Fujimura","year":"1997","unstructured":"Fujimura M, Tominaga T, Kato I et al (1997) Attenuation of nitric oxide synthase induction in IRF-1-deficient glial cells. Brain Res 759:247\u2013250","journal-title":"Brain Res"},{"key":"1514_CR49","doi-asserted-by":"crossref","first-page":"C144","DOI":"10.1152\/ajprenal.0064.2001","volume":"282","author":"X Teng","year":"2002","unstructured":"Teng X, Zhang H, Snead C, Catravas JD (2002) Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Am J Physiol Cell Physiol 282:C144\u2013C152","journal-title":"Am J Physiol Cell Physiol"},{"key":"1514_CR50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1074\/jbc.M109819200","volume":"277","author":"LA Blair","year":"2002","unstructured":"Blair LA, Maggi LB Jr, Scarim AL, Corbett JA (2002) Role of interferon regulatory factor-1 in double-stranded RNA-induced iNOS expression by mouse islets. J Biol Chem 277:359\u2013365","journal-title":"J Biol Chem"},{"key":"1514_CR51","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s001250051036","volume":"41","author":"MI Darville","year":"1998","unstructured":"Darville MI, Eizirik DL (1998) Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41:1101\u20131108","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1514-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-009-1514-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1514-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:47:14Z","timestamp":1558612034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-009-1514-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,8]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1007\/s00125-009-1514-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,8]]}}}